Qube Research & Technologies (QRT)
KYTX icon

Qube Research & Technologies (QRT)’s Kyverna Therapeutics KYTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88M Buy
333,692
+270,076
+425% +$2.25M ﹤0.01% 1957
2025
Q4 		$598K Buy
63,616
+26,925
+73% +$200K ﹤0.01% 2748
2025
Q3 		$220K Buy
36,691
+22,640
+161% +$90.5K ﹤0.01% 2924
2025
Q2 		$43.1K Buy
+14,051
New +$34.8K ﹤0.01% 3178
2024
Q3 		– Sell
-42,424
Closed -$318K – 4256
2024
Q2 		$318K Sell
42,424
-26,813
-39% -$410K ﹤0.01% 2288
2024
Q1 		$1.72M Buy
+69,237
New +$1.93M ﹤0.01% 1844

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KYTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Kyverna Therapeutics (KYTX) stake by 425% in Q1 2026, buying an estimated $2.25M and bringing the position to 333,692 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Qube Research & Technologies (QRT) first reported a position in KYTX in Q1 2024 and has held it in 6 quarters since. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 333,692 shares of Kyverna Therapeutics worth $2.88M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 270,076 Kyverna Therapeutics shares in Q1 2026, an estimated $2.25M.
  • Kyverna Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1957 holding.
  • Qube Research & Technologies (QRT) first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.